Scientists just found a hidden escape route that lets cells keep making a life-saving building block even after their main safety system completely shuts down.
Quick Take
- Researchers at Montana State University identified a new biochemical pathway that produces cysteine, a molecule cells need to survive stress and disease.
- The pathway activates only when a cell’s normal disulfide reductase system is missing or disabled, a condition once thought to be fatal for cells.
- The process breaks a carbon-sulfur bond inside cystine, creating a byproduct that turns into usable cysteine on its own.
- The findings, published in Nature Chemical Biology, could point scientists toward new ways to target cancer cells that rely on this same survival trick.
A Backup System Nobody Expected
Every cell needs cysteine, a small but powerful molecule used to build proteins and fight off damage. For decades, scientists believed cells had a fixed set of tools to make it, and that losing the main system would spell doom. Researchers led by molecular geneticist Edward E. Schmidt found something different. Their study, published in Nature Chemical Biology, describes a pathway the authors call “previously unrecognized”.
The discovery came from studying liver cells engineered to lack two enzymes called thioredoxin reductase and glutathione reductase. Together these enzymes normally handle a huge share of a cell’s cleanup and repair work. Without them, cells should struggle badly. Instead, the team found these cells kept producing cysteine through a route nobody had mapped before, even as cystine levels built up around them.
How the Newfound Pathway Works
The mechanism is specific and traceable. A vitamin B6-dependent reaction cuts a carbon-sulfur bond inside cystine, the oxidized, paired-up form of cysteine. That cut produces a compound called cysteine persulfide, which then breaks down on its own into usable cysteine, without needing extra enzymes to finish the job. Coverage from ScienceDaily described it as a “surprising backup system” that works even when pathways once thought essential are switched off.
Most of the cysteine found in these reductase-deficient liver cells came from this new route, not from older, well-known pathways like transsulfuration, according to the study’s own findings. The research team also suggested the pathway may switch on more broadly, in many mammalian cell types, whenever cystine builds up too high inside a cell for too long.
Why Cysteine Matters So Much for Cancer Cells
Cysteine is not just a maintenance molecule. It feeds into glutathione, the compound cells use to guard against a type of cell death called ferroptosis, which is driven by damage to fats inside the cell. Cancer researchers have spent years studying how tumors protect themselves by keeping cysteine and glutathione supplies flowing, since starving a tumor of cysteine is one strategy for killing it.
Scientists already knew cells could pull cysteine from several sources, including direct uptake of cystine and a process called transsulfuration, which converts the amino acid methionine into cysteine through a multi-step chain. The newly identified pathway does not replace those older routes. It adds another option, one that appears specifically when a cell’s front-line defense system fails and cystine piles up, a scenario relevant to tumors under chemical or immune stress.
What Comes Next for This Discovery
Because tumors often face exactly the kind of oxidative stress that could trigger this backup pathway, researchers see a potential opening. If cancer cells lean on this newfound cysteine source to survive treatment, blocking it might make existing therapies hit harder. That idea remains a research direction rather than a proven treatment, since the current findings center on liver cells lacking specific enzymes.
Scientists discover an “impossible” cellular survival pathway that could help fight cancer | Montana State University
Scientists discovered a surprising backup system that lets mammalian cells make the essential amino acid cysteine even when the pathways once considered… pic.twitter.com/nx28EaNEUG
— Owen Gregorian (@OwenGregorian) September 25, 2026
The research team, which included coauthors from Montana State University and international collaborators, is positioned to expand this work into other tissue types and disease models. Given how central cysteine and glutathione are to cancer cell survival, a confirmed second cysteine pipeline gives drug developers a fresh target to study, and gives conservative-minded taxpayers who fund basic science research a concrete example of discovery paying off.
Sources:
sciencedaily.com, ambic.org, phys.org, cell.com
